CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 1 enrolled
Drug / intervention
bupropion & Citalopram +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01716221
NCT01716221Phase 4Completed
CompareCT.gov

An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia

University of Colorado, Denver·interventional·Posted Oct 29, 2012·Updated Sep 19, 2016

In Brief

A Phase 4 clinical trial evaluating bupropion & Citalopram, Bupropion & Placebo, and 2 other interventions for Friedreich Ataxia. Completed, enrolled 1 participant.

Detailed Summary

The purpose of this study is to document the clinical effects of bupropion and citalopram in a single subject with Friedreich Ataxia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFriedreich Ataxia
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedOct 29, 2012
Enrollment StartOct 1, 2012
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 13.7 years ago

Interventions

bupropion & Citalopramdrug

Bupropion & Placebodrug

Placebo & Citalopramdrug

Placebo & Placebodrug